Financhill
Back

Apellis Pharmaceuticals Quote, Financials, Valuation and Earnings

New AI Stock Payouts

Watch this presentation before then!
Sell
50

APLS
Apellis Pharmaceuticals

Last Price:
63.88
Seasonality Move:
16.07%

7 Day Trial

ALL ACCESS PASS

$ 7

The "Scaled Selling Technique"

Click here for more details...

Apellis Pharmaceuticals Price Quote

$63.88
+0.02 (+3.08%)
(Updated: March 2, 2024 at 7:16 AM ET)

Apellis Pharmaceuticals Key Stats

Sell
50
Apellis Pharmaceuticals (APLS) is a Sell

Day range:
$61.52 - $65.74
52-week range:
$19.83 - $94.75
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
19.11
P/B ratio:
39.59%

Volume:
2.6M
Avg. volume:
1.5M
1-year change:
-0.22%
Market cap:
$7.7B
Revenue:
$396.6M
EPS:
$-4.48

How Much Does Apellis Pharmaceuticals Make?

Is Apellis Pharmaceuticals Growing As A Company?

Apellis Pharmaceuticals Stock Price Performance

What Is Apellis Pharmaceuticals 52-Week High & Low?

Apellis Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Apellis Pharmaceuticals?

Is Apellis Pharmaceuticals Cash Flow Positive?

  • What Is APLS Cash Flow From Operations?
    Cash flow from operations (TTM) is -$594.7M
  • What Is Apellis Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $394.5M
  • What Is Apellis Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$674K

Apellis Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    APLS return on invested capital is -145.34%
  • What Is Apellis Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is -62.02%
  • What Is APLS Return On Equity?
    ROE is a measure of profitability and is -195.18%

Apellis Pharmaceuticals Earnings Date & Stock Price

Apellis Pharmaceuticals Competitors

Apellis Pharmaceuticals Dividend Yield

Data Unavailable

Apellis Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -3.73%
Revenue: 545.89% 1.94%

Analyst Recommendations

Buy Recommendations: 10
Hold Recommendations: 3
Sell Recommendations: 0
Price Target: 82.50
Upside from Last Price: 29.19%

Major Shareholders

  • How many APLS shares are owned by institutional investors?
    166.1M APLS shares are owned by institutional investors
  • How many APLS shares are owned by insiders?
    3.8M APLS shares are owned by insiders